Cargando…
Adenoviral Vectors: Potential as Anti-HBV Vaccines and Therapeutics
Adenoviral vaccines have been at the front line in the fight against pandemics caused by viral infections such as Ebola and the coronavirus disease 2019. This has revived an interest in developing these vectors as vaccines and therapies against other viruses of health importance such as hepatitis B...
Autores principales: | Farhad, Tasneem, Neves, Keila, Arbuthnot, Patrick, Maepa, Mohube Betty |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9689594/ https://www.ncbi.nlm.nih.gov/pubmed/36360178 http://dx.doi.org/10.3390/genes13111941 |
Ejemplares similares
-
Advances in designing Adeno-associated viral vectors for development of anti-HBV gene therapeutics
por: Mnyandu, Njabulo, et al.
Publicado: (2021) -
Progress and Prospects of Anti-HBV Gene Therapy Development
por: Maepa, Mohube B., et al.
Publicado: (2015) -
Gene Therapy for Chronic HBV—Can We Eliminate cccDNA?
por: Bloom, Kristie, et al.
Publicado: (2018) -
Inhibition of Hepatitis B Virus Replication by Helper Dependent Adenoviral Vectors Expressing Artificial Anti-HBV Pri-miRs from a Liver-Specific Promoter
por: Mowa, Mohube Betty, et al.
Publicado: (2014) -
Sustained Inhibition of HBV Replication In Vivo after Systemic Injection of AAVs Encoding Artificial Antiviral Primary MicroRNAs
por: Maepa, Mohube Betty, et al.
Publicado: (2017)